Cargando…
Prospects and Challenges for T Cell-Based Therapies of HCC
The scope of therapeutic options for the treatment of hepatocellular carcinoma (HCC) has recently been expanded by immunotherapeutic regimens. T cell-based therapies, especially in combination with other treatments have achieved far better outcomes compared to conventional treatments alone. However,...
Autores principales: | Woller, Norman, Engelskircher, Sophie Anna, Wirth, Thomas, Wedemeyer, Heiner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304292/ https://www.ncbi.nlm.nih.gov/pubmed/34209393 http://dx.doi.org/10.3390/cells10071651 |
Ejemplares similares
-
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
por: Dong, Yawen, et al.
Publicado: (2021) -
Age-specific and sex-specific risks for HCC in African-born persons with chronic hepatitis B without cirrhosis
por: Kamal, Habiba, et al.
Publicado: (2023) -
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations
por: Edeline, Julien, et al.
Publicado: (2022) -
Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022) -
HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)